[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100522398":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":11,"centralContacts":35,"locations":41,"responsibleParty":274,"collaborators":11,"id":276,"slug":277,"hasResults":278,"nctId":279,"briefTitle":280,"officialTitle":281,"acronym":11,"eligibilityCriteria":282,"healthyVolunteers":278,"sex":283,"minAge":284,"maxAge":11,"enrollmentInfo":285,"targetDuration":11,"studyType":288,"phases":289,"briefSummary":291,"conditions":292,"keywords":11,"overallStatus":44,"whyStopped":11,"lastUpdateSubmitDate":294,"lastUpdatePostDateStruct":295,"startDateStruct":298,"completionDateStruct":300,"leadSponsor":302,"locationsCount":303},{"fullName":5,"class":6},"Beijing InnoCare Pharma Tech Co., Ltd.","INDUSTRY",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Orelabrutinib","EXPERIMENTAL",null,[13,14],"Drug: Orelabrutinib","Drug: Rituximab",{"label":16,"type":17,"description":11,"interventionNames":18},"Comparator","ACTIVE_COMPARATOR",[19,14],"Drug: Lenalidomide",[21,25,29,33],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":11},"DRUG","Orelabrutinib Tablets",[9],{"type":22,"name":26,"description":27,"armGroupLabels":28,"otherNames":11},"Rituximab","Rituximab Injection",[9],{"type":22,"name":30,"description":31,"armGroupLabels":32,"otherNames":11},"Lenalidomide","Lenalidomide Capsules",[16],{"type":22,"name":26,"description":27,"armGroupLabels":34,"otherNames":11},[16],[36],{"name":37,"role":38,"phone":39,"phoneExt":11,"email":40},"Alexia Lu","CONTACT","010-66609745","CO_HGRAC@innocarepharma.com",[42,59,72,81,94,103,116,124,137,151,164,173,186,197,210,222,235,248,261],{"facility":43,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"The First Affiliated Hospital of Bengbu Medical College","RECRUITING","Bengbu","Auhui","233000","China","CN",{"type":51,"coordinates":52},"Point",[53,54],117.36083,32.94083,{"lat":54,"lon":53},[57],{"name":58,"role":38,"phone":11,"phoneExt":11,"email":11},"Yanli Yang",{"facility":60,"status":44,"city":61,"state":62,"zip":63,"country":48,"countryCode":49,"cosmosGeoPoint":64,"geoPoint":68,"contacts":69},"Beijing Tiantan Hospital, Capital Medical University","Beijing","Beijing Municipality","100070",{"type":51,"coordinates":65},[66,67],116.39723,39.9075,{"lat":67,"lon":66},[70],{"name":71,"role":38,"phone":11,"phoneExt":11,"email":11},"Lin Fu",{"facility":73,"status":44,"city":61,"state":62,"zip":74,"country":48,"countryCode":49,"cosmosGeoPoint":75,"geoPoint":77,"contacts":78},"Beijing Tongren Hospital, Capital Medical University","100730",{"type":51,"coordinates":76},[66,67],{"lat":67,"lon":66},[79],{"name":80,"role":38,"phone":11,"phoneExt":11,"email":11},"Liang Wang",{"facility":82,"status":44,"city":83,"state":84,"zip":85,"country":48,"countryCode":49,"cosmosGeoPoint":86,"geoPoint":90,"contacts":91},"Sun Yat-sen University Cancer Center","Guangzhou","Guangdong","510055",{"type":51,"coordinates":87},[88,89],113.25,23.11667,{"lat":89,"lon":88},[92],{"name":93,"role":38,"phone":11,"phoneExt":11,"email":11},"Huiqiang Huang",{"facility":95,"status":44,"city":83,"state":84,"zip":96,"country":48,"countryCode":49,"cosmosGeoPoint":97,"geoPoint":99,"contacts":100},"Guangdong Provincial Hospital of Chinese Medicine","510120",{"type":51,"coordinates":98},[88,89],{"lat":89,"lon":88},[101],{"name":102,"role":38,"phone":11,"phoneExt":11,"email":11},"Xiping Dai",{"facility":104,"status":44,"city":105,"state":106,"zip":107,"country":48,"countryCode":49,"cosmosGeoPoint":108,"geoPoint":112,"contacts":113},"Henan Cancer Hospital","Zhengzhou","Henan","450003",{"type":51,"coordinates":109},[110,111],113.64861,34.75778,{"lat":111,"lon":110},[114],{"name":115,"role":38,"phone":11,"phoneExt":11,"email":11},"Keshu Zhou",{"facility":117,"status":44,"city":105,"state":106,"zip":107,"country":48,"countryCode":49,"cosmosGeoPoint":118,"geoPoint":120,"contacts":121},"Henan Provincial Peoples Hospital",{"type":51,"coordinates":119},[110,111],{"lat":111,"lon":110},[122],{"name":123,"role":38,"phone":11,"phoneExt":11,"email":11},"Zunmin Zhu",{"facility":125,"status":44,"city":126,"state":127,"zip":128,"country":48,"countryCode":49,"cosmosGeoPoint":129,"geoPoint":133,"contacts":134},"Union Hospital Tongji Medical College Huazhong University of Science and Technology","Wuhan","Hubei","430000",{"type":51,"coordinates":130},[131,132],114.26667,30.58333,{"lat":132,"lon":131},[135],{"name":136,"role":38,"phone":11,"phoneExt":11,"email":11},"Yu Hu",{"facility":138,"status":139,"city":140,"state":141,"zip":142,"country":48,"countryCode":49,"cosmosGeoPoint":143,"geoPoint":147,"contacts":148},"Hunan Cancer Hospital","NOT_YET_RECRUITING","Changsha","Hunan","410000",{"type":51,"coordinates":144},[145,146],112.97087,28.19874,{"lat":146,"lon":145},[149],{"name":150,"role":38,"phone":11,"phoneExt":11,"email":11},"Yajun Li",{"facility":152,"status":44,"city":153,"state":154,"zip":155,"country":48,"countryCode":49,"cosmosGeoPoint":156,"geoPoint":160,"contacts":161},"The First Affiliated Hospital of Nanchang University","Nanchang","Jiangxi","330006",{"type":51,"coordinates":157},[158,159],115.85306,28.68396,{"lat":159,"lon":158},[162],{"name":163,"role":38,"phone":11,"phoneExt":11,"email":11},"Fei Li",{"facility":165,"status":44,"city":153,"state":154,"zip":166,"country":48,"countryCode":49,"cosmosGeoPoint":167,"geoPoint":169,"contacts":170},"Jiangxi Cancer Hospital","330029",{"type":51,"coordinates":168},[158,159],{"lat":159,"lon":158},[171],{"name":172,"role":38,"phone":11,"phoneExt":11,"email":11},"Wuping Li",{"facility":174,"status":44,"city":175,"state":176,"zip":177,"country":48,"countryCode":49,"cosmosGeoPoint":178,"geoPoint":182,"contacts":183},"The Second Hospital of Dalian Medical University","Dalian","Liaoning","116023",{"type":51,"coordinates":179},[180,181],121.60222,38.91222,{"lat":181,"lon":180},[184],{"name":185,"role":38,"phone":11,"phoneExt":11,"email":11},"Xiaojing Yan",{"facility":187,"status":44,"city":188,"state":176,"zip":189,"country":48,"countryCode":49,"cosmosGeoPoint":190,"geoPoint":194,"contacts":195},"The first Hospital of China Medical University","Shenyang","110002",{"type":51,"coordinates":191},[192,193],123.43278,41.79222,{"lat":193,"lon":192},[196],{"name":185,"role":38,"phone":11,"phoneExt":11,"email":11},{"facility":198,"status":139,"city":199,"state":200,"zip":201,"country":48,"countryCode":49,"cosmosGeoPoint":202,"geoPoint":206,"contacts":207},"The Affiliated Hospital Of Qingdao University","Qingdao","Shandong","266000",{"type":51,"coordinates":203},[204,205],120.38042,36.06488,{"lat":205,"lon":204},[208],{"name":209,"role":38,"phone":11,"phoneExt":11,"email":11},"Xia Zhao",{"facility":211,"status":44,"city":212,"state":200,"zip":213,"country":48,"countryCode":49,"cosmosGeoPoint":214,"geoPoint":218,"contacts":219},"Yantai Yuhuangding Hospital","Yantai","264099",{"type":51,"coordinates":215},[216,217],121.44081,37.47649,{"lat":217,"lon":216},[220],{"name":221,"role":38,"phone":11,"phoneExt":11,"email":11},"Xiaoxia Chu",{"facility":223,"status":44,"city":224,"state":225,"zip":226,"country":48,"countryCode":49,"cosmosGeoPoint":227,"geoPoint":231,"contacts":232},"Fudan University Shanghai Cancer Center","Shanghai","Shanghai Municipality","200040",{"type":51,"coordinates":228},[229,230],121.45806,31.22222,{"lat":230,"lon":229},[233],{"name":234,"role":38,"phone":11,"phoneExt":11,"email":11},"Yan Yuan",{"facility":236,"status":44,"city":237,"state":238,"zip":239,"country":48,"countryCode":49,"cosmosGeoPoint":240,"geoPoint":244,"contacts":245},"The Second Affiliated Hospital of Xi'an Jiaotong University（Xibei Hospital）","Xi’an","Shanxi","710004",{"type":51,"coordinates":241},[242,243],113.52486,35.99785,{"lat":243,"lon":242},[246],{"name":247,"role":38,"phone":11,"phoneExt":11,"email":11},"Wanhong Zhao",{"facility":249,"status":139,"city":250,"state":251,"zip":252,"country":48,"countryCode":49,"cosmosGeoPoint":253,"geoPoint":257,"contacts":258},"West China Hospital, Sichuan University","Chengdu","Sichuan","610041",{"type":51,"coordinates":254},[255,256],104.06667,30.66667,{"lat":256,"lon":255},[259],{"name":260,"role":38,"phone":11,"phoneExt":11,"email":11},"Liqun Zou",{"facility":262,"status":44,"city":263,"state":264,"zip":265,"country":48,"countryCode":49,"cosmosGeoPoint":266,"geoPoint":270,"contacts":271},"The First Affiliated Hospital of Zhejiang University School of Medicine","Hangzhou","Zhejiang","310003",{"type":51,"coordinates":267},[268,269],120.16142,30.29365,{"lat":269,"lon":268},[272],{"name":273,"role":38,"phone":11,"phoneExt":11,"email":11},"Wenjuan Yu",{"type":275,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100522398","phase-3-efficacy-and-safety-of-orelabrutinib-combined-with-rituximab-versus-lenalidomide-combined-with-rituximab-in-patients-with-relapsedrefractory-marginal-zone-lymphoma-100522398",false,"NCT06082102","Efficacy and Safety of Orelabrutinib Combined With Rituximab Versus Lenalidomide Combined With Rituximab in Patients With Relapsed\u002FRefractory Marginal Zone Lymphoma","A Randomized, Controlled, Open-label, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Orelabrutinib Plus Rituximab Versus Lenalidomide Plus Rituximab in Relapsed\u002FRefractory Marginal Zone Lymphoma","Inclusion Criteria:\n\n1. Age ≥ 18 years , either sex.\n2. Histopathologically confirmed B-cell non-Hodgkin lymphoma MZL (splenic, nodal, or extra-nodal).\n3. Prior systemic therapy including at least one anti-CD20 monoclonal antibody-containing regimen is required, with the following specifications:\n\n   For combination therapies: Minimum of 2 completed treatment cycles For anti-CD20 monotherapy: Minimum of 4 administered doses Progression during treatment waives cycle\u002Fdose requirements\n4. Relapsed or refractory disease.\n5. At least 1 measurable lesion confirmed through enhanced computed tomography (CT) or enhanced magnetic resonance imaging (MRI).\n6. ECOG performance status (PS) score of 0-2.\n\nExclusion Criteria:\n\n1. Administration of the specified anti-tumor therapies within 2 weeks prior to the first dose of the study treatment.\n2. Administration of any other investigational product within 4 weeks prior to the first dose of the study treatment, or concurrent participation in another clinical trial.(Excluding patients who have discontinued treatment and are in long-term follow-up).\n3. Prior treatment with any types of BTK inhibitor.\n4. Patients refractory to lenalidomide plus rituximab (R2 regimen). Refractoriness is defined as either: Failure to achieve at least partial response (PR) after completing an adequate R2 treatment course (≥2 cycles at standard doses), OR Disease progression during R2 therapy or within 6 months after the last dose.\n5. Central nervous system (CNS) lymphoma, and lymphoma with CNS or meningeal involvements.","ALL","18 Years",{"count":286,"type":287},324,"ESTIMATED","INTERVENTIONAL",[290],"PHASE3","Efficacy and Safety of Orelabrutinib Combined with Rituximab versus Lenalidomide Combined with Rituximab in Patients with Relapsed\u002FRefractory Marginal Zone Lymphoma",[293],"Relapsed\u002FRefractory Marginal Zone Lymphoma","2025-09-12",{"date":296,"type":297},"2025-09-15","ACTUAL",{"date":299,"type":297},"2023-12-19",{"date":301,"type":287},"2030-02-25",{"name":5,"class":6},19]